Granulocyte precursor cell

Granulocyte precursor cells are immature cells within the bone marrow that develop along the granulocyte lineage and ultimately give rise to the mature granulocytes: neutrophils, eosinophils, and basophils[9][1][7]. The defined precursor stages include myeloblasts, promyelocytes, myelocytes, and metamyelocytes[9][7]. These cells are crucial intermediates in hematopoiesis[1][7]. They are not themselves direct molecular therapeutic targets, but their dynamics underlie normal immune function, and their dysregulation or depletion is implicated in a variety of diseases, such as leukemias and marrow failure syndromes[1][9][3][7]. Caveat: "Granulocyte precursor cell" is a developmental cell type, not a target molecule or receptor; it does not fit the definition of a canonical molecular drug target[9][1][7].

Other names

Granulocytic precursor cellMyeloblast (earliest precursor stage)PromyelocyteMyelocyteMetamyelocytePre-neutrophil (preneu; subset terminology in recent studies)

No direct mechanisms as a drug target; agents like G-CSF stimulate downstream differentiation of precursors into functional granulocytes.